Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
05 janv. 2018 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company working to improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
02 janv. 2018 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer
26 déc. 2017 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 26, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments
11 déc. 2017 16h05 HE
|
Peregrine Pharmaceuticals Inc.
-- Avid Bioservices Records Revenues of $12.8 Million in the Second Quarter of FY2018 -- -- Transition to a Dedicated CDMO Business Nearing Completion -- TUSTIN, Calif., Dec. 11, 2017 ...
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock
07 déc. 2017 16h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...
Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017
04 déc. 2017 16h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement
28 nov. 2017 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif. and CHICAGO, Ill., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) (“Peregrine”) and Ronin Trading, LLC and SW Investment Management...
Peregrine Announces Date of 2017 Annual Meeting of Stockholders
13 nov. 2017 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) today announced that its 2017 Annual Meeting of Stockholders will be held on January...
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
24 oct. 2017 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
19 oct. 2017 08h05 HE
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...